APA

Ali A. N., Zhang P., Yung W. K. A., Chen Y., Movsas B., Urtasun R. C., Jones C. U., Choi K. N., Michalski J. M., Fischbach A. J., Markoe A. M., Schultz C. J., Penas-Prado M., Garg M. K., Hartford A. C., Kim H. E., Won M. & Curran W. J. (20190218). NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. : Journal of neuro-oncology.

Chicago

Ali Arif N, Zhang Peixin, Yung W K Alfred, Chen Yuhchyau, Movsas Benjamin, Urtasun Raul C, Jones Christopher U, Choi Kwang N, Michalski Jeff M, Fischbach A Jennifer, Markoe Arnold M, Schultz Christopher J, Penas-Prado Marta, Garg Madhur K, Hartford Alan C, Kim Harold E, Won Minhee and Curran Walter J. 20190218. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. : Journal of neuro-oncology.

Harvard

Ali A. N., Zhang P., Yung W. K. A., Chen Y., Movsas B., Urtasun R. C., Jones C. U., Choi K. N., Michalski J. M., Fischbach A. J., Markoe A. M., Schultz C. J., Penas-Prado M., Garg M. K., Hartford A. C., Kim H. E., Won M. and Curran W. J. (20190218). NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. : Journal of neuro-oncology.

MLA

Ali Arif N, Zhang Peixin, Yung W K Alfred, Chen Yuhchyau, Movsas Benjamin, Urtasun Raul C, Jones Christopher U, Choi Kwang N, Michalski Jeff M, Fischbach A Jennifer, Markoe Arnold M, Schultz Christopher J, Penas-Prado Marta, Garg Madhur K, Hartford Alan C, Kim Harold E, Won Minhee and Curran Walter J. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. : Journal of neuro-oncology. 20190218.